6-thioguanine, an antimetabolite not potentiated by allopurinol, has been used in the treatment of 29 patients with polycythemia Vera. All but two of the patients had been treated previously by venesection and/or radioactive phosphorus (32p) and/or alkylating agents. The usual dose was 40-160 mg dai
β¦ LIBER β¦
Peripheral retinal neovascularization associated with polycythemia rubra vera
β Scribed by Radhika Krishnan
- Book ID
- 106327577
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 258 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0021-5155
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Secondary treatment of polycythemia rubr
β
Dr. D. W. Milligan; S. L. Thein; B. E. Roberts
π
Article
π
1982
π
John Wiley and Sons
π
English
β 268 KB
π 2 views
Acquired von willebrand disease in patie
β
Hiroshi Mohri
π
Article
π
1987
π
John Wiley and Sons
π
English
β 688 KB
Fulminant BuddβChiari syndrome associate
β
Murat Akyildiz; Zeki Karasu; Hamad Dheir; Necla Osmanoglu; Sinan Akay; Tankut Il
π
Article
π
2006
π
Elsevier Science
π
English
β 64 KB
POEMS syndrome associated with polycythe
β
William Schulz; Donald Domenico; Sucha Nand
π
Article
π
1989
π
John Wiley and Sons
π
English
β 457 KB
π 2 views
LONG-TERM CONTROL OF POLYCYTHEMIA RUBRA
β
M. J. CLEMONS; Y. F. WILLIAMS; J. M. GOLDMAN; A. J. BARRETT
π
Article
π
1996
π
John Wiley and Sons
π
English
β 224 KB
π 2 views
The natural history of PRV is characterized by a prolonged period of myeloproliferation chiefly affecting the red cell series. It can be controlled by venesection and cytotoxic agents. In this case report the patient declined further 'standard' chemotherapy to control his disease and the use of rela
Retinal neovascularization associated wi
β
R. Keith Shuler Jr; G. Baker Hubbard III; Hans E. Grossniklaus
π
Article
π
2005
π
Elsevier Science
π
English
β 136 KB